信息

信息
GEXVal's Drug Repurposing Study Using GATE-Based AI Technology Published in Journal “Pharmaceuticals”New!!

株式会社GEXVal September 25, 2026 GEXVal Publishes COVID-19 Drug Repurposing Study Using Its AI Technology GATE in […]

Read more
信息
GEXVal to present AI Drug Discovery Platform RePhaIND® at BioJapan SeminarNew!!

株式会社GEXVal September 25, 2026 GEXVal Inc. to Present at BioJapan 2026 Seminar “From Analytical AI to Explorato […]

Read more
信息
GEXVal to Exhibit at BioJapan 2026New!!

株式会社GEXVal September 25, 2026 GEXVal to Showcase AI-Powered Drug Discovery Platform RePhaIND® at BioJapan 2026 […]

Read more
信息
GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026"

株式会社GEXVal September 18, 2026 GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026" […]

Read more
信息
GEXVal CEO Invited to Speak at "YOKOHAMA DEEP TECH GLOBAL BRIDGE 2026"

株式会社GEXVal September 15, 2026 GEXVal CEO Invited to Speak at "YOKOHAMA DEEP TECH GLOBAL BRIDGE 2026"   GE […]

Read more